ESMO AI 2026 conference preview covering AI in oncology, precision oncology and emerging clinical applications.

ESMO AI 2026 Preview: AI in Oncology and Clinical Implementation

ESMO 2026 at a glance ESMO AI 2026 will bring attention to developments in…


Lucid Diligence Brief - Tech

Nucleai-University of Glasgow Partnership Expands Spatial AI Platform | Lucid Diligence Brief

Nucleai broadened its University of Glasgow collaboration to expand academic…


Lucid Diligence Brief - Tech

Lucid Diligence Brief: Roche to acquire PathAI

Lucid Diligence Brief: Roche acquires PathAI for USD 1.05B to advance AI…


Lucid Diligence Brief - Tech

Lucid Diligence Brief: AstraZeneca to acquire Modella AI

Lucid Diligence Brief: AstraZeneca to acquire Modella AI Professional audiences…


ESMO Immuno-Oncology 2025 Preview: Key Highlights to Watch

ESMO Immuno-Oncology 2025 at a glance Get ready for ESMO Immuno-Oncology…


ESMO AI 2025 Preview: What to Watch in Oncology and AI

ESMO AI at a glance Get ready for ESMO AI and Digital Oncology 2025…


Artificial_Intelligence

Artificial Intelligence and Digital Health Weekly News - August 18th 2025

AI in Healthcare Update: China’s AI Drug Discovery, GPT-five Medical Reasoning,…


Artificial_Intelligence

Artificial Intelligence and Digital Health Weekly News - August 12th 2025

AI in Healthcare Update: GPT-five Launch, NASA Medical AI, Wearable…


Privacy Preference Center